Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/NBIX
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Neurocrine Biosciences Inc (NBIX) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Neurocrine Biosciences (NBIX) trades at $135.71, down 0.91% on the day, with a bearish technical signal but strong fundamentals. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $2.85 significantly exceeding the $1.85 estimate. Revenue grew to $2.86 billion in 2025, with a net income margin of 20.91% and high profitability metrics. Recent news highlights pipeline advancements and conference participation.
The outlook is positive given strong analyst consensus (86.49% buy ratings) and a $204.18 price target, implying significant upside. Key risks include execution of pipeline diversification and potential pricing pressures on key drug Ingrezza. The stock presents a growth opportunity driven by product launches and expanding rare-disease portfolio, though technical weakness near-term warrants monitoring.
Read full analysis

Key Stats

  • Market Cap
    $13.79B
  • Volume
    1,076,612
  • Sector
    Health
  • 52W High
    $185.50
  • 52W Low
    $123.10
  • Typical Hold Time
    25 Days
  • Enterprise Value
    $13.81B
  • Div Yield
    -
  • Trading Activity
    -
$135.71
52W Low: $123.1
12 Feb 2026
52W High: $185.5
30 Jul 2026

Track Neurocrine Biosciences Inc (NBIX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Neurocrine Biosciences Inc has traded between a low of $123.1 and a high of $185.5, highlighting its annual price range. Buy and sell Neurocrine Biosciences Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Most Recent News

Content is generated by Aura AI

Congress votes to release sexual misconduct settlement records amid major Trump admin updates on fraud, energy, and jobs.

In the 91st week of President Trump's second term, Congress voted unanimously (420-0) to publicly release taxpayer-funded sexual misconduct settlement records. The Trump administration also reported significant actions including dismantling millions ...

Market News
3 hours ago
Thinkcarebelieve
Bearish
news icon
Congress votes to release sexual misconduct settlement records amid major Trump admin updates on fraud, energy, and jobs.

Market shifts from AI and growth stocks to value and defensive sectors amid election uncertainty.

Recent market trends show investors moving away from AI and growth stocks, especially semiconductors like NVDA and AVGO, toward value and defensive sectors such as consumer staples. Despite a broad decline in major tech stocks, Apple has remained res...

Market News
4 hours ago
Seeking Alpha
Neutral
Market shifts from AI and growth stocks to value and defensive sectors amid election uncertainty.

Grab's $1.49B Atome deal boosts fintech growth, signaling long-term revenue gains in SE Asia.

Grab Holdings is set for multi-year growth in revenue and earnings across Southeast Asia's ride-hailing, delivery, and fintech sectors. Its recent share price dip may offer a buying opportunity for long-term investors. The company plans to acquire a ...

Market News
4 hours ago
Seeking Alpha
Bullish
news icon
Grab's $1.49B Atome deal boosts fintech growth, signaling long-term revenue gains in SE Asia.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $13.79B
  • Volume
    1,076,612
  • Sector
    Health
  • 52W High
    $185.50
  • 52W Low
    $123.10
  • Typical Hold Time
    25 Days
  • Enterprise Value
    $13.81B
  • Div Yield
    -
  • Trading Activity
    -
$135.71
52W Low: $123.1
12 Feb 2026
52W High: $185.5
30 Jul 2026

Track Neurocrine Biosciences Inc (NBIX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Neurocrine Biosciences Inc has traded between a low of $123.1 and a high of $185.5, highlighting its annual price range. Buy and sell Neurocrine Biosciences Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!